Summit Global Investments’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-7,964
| Closed | -$740K | – | 579 |
|
|
2021
Q1 | $740K | Buy |
7,964
+664
| +9% | +$61.7K | 0.05% | 248 |
|
|
2020
Q4 | $654K | Buy |
7,300
+66
| +0.9% | +$5.91K | 0.07% | 177 |
|
|
2020
Q3 | $747K | Sell |
7,234
-7,761
| -52% | -$801K | 0.08% | 160 |
|
|
2020
Q2 | $1.19M | Sell |
14,995
-200
| -1% | -$15.8K | 0.14% | 109 |
|
|
2020
Q1 | $879K | Sell |
15,195
-3,100
| -17% | -$179K | 0.13% | 95 |
|
|
2019
Q4 | $987K | Buy |
18,295
+4,275
| +30% | +$231K | 0.11% | 123 |
|
|
2019
Q3 | $733K | Buy |
+14,020
| New | +$733K | 0.09% | 231 |
|
|
2018
Q4 | – | Sell |
-12,800
| Closed | -$843K | – | 264 |
|
|
2018
Q3 | $843K | Hold |
12,800
| – | – | 0.11% | 152 |
|
|
2018
Q2 | $646K | Buy |
12,800
+1,100
| +9% | +$55.5K | 0.1% | 207 |
|
|
2018
Q1 | $616K | Buy |
+11,700
| New | +$616K | 0.1% | 132 |
|